CVA: Reducing the risk of a confused vascular analysis - The Feinberg lecture

被引:11
作者
Furlan, AJ
机构
[1] Stroke/Neurol. Inten. Care Head Sec., Department of Neurology, Cleveland Clinic, Cleveland, OH 44195
关键词
American Heart Association; cerebrovascular disorders; clinical trials; stroke classification;
D O I
10.1161/01.STR.31.6.1451
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:1451 / 1456
页数:6
相关论文
共 31 条
[2]   Quality of health care .6. The role of physicians in the future of quality management [J].
Blumenthal, D ;
Epstein, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (17) :1328-1331
[3]   MEASUREMENTS OF ACUTE CEREBRAL INFARCTION - A CLINICAL EXAMINATION SCALE [J].
BROTT, T ;
ADAMS, HP ;
OLINGER, CP ;
MARLER, JR ;
BARSAN, WG ;
BILLER, J ;
SPILKER, J ;
HOLLERAN, R ;
EBERLE, R ;
HERTZBERG, V ;
RORICK, M ;
MOOMAW, CJ ;
WALKER, M .
STROKE, 1989, 20 (07) :864-870
[4]   TIAS - WE NEED TO RETURN TO THE QUESTION, WHAT IS WRONG WITH JONES [J].
CAPLAN, LR .
NEUROLOGY, 1988, 38 (05) :791-793
[5]   THE WARFARIN-ASPIRIN SYMPTOMATIC INTRACRANIAL DISEASE STUDY [J].
CHIMOWITZ, MI ;
KOKKINOS, J ;
STRONG, J ;
BROWN, MB ;
LEVINE, SR ;
SILLIMAN, S ;
PESSIN, MS ;
WEICHEL, E ;
SILA, CA ;
FURLAN, AJ ;
KARGMAN, DE ;
SACCO, RL ;
WITYK, RJ ;
FORD, G ;
FAYAD, PB .
NEUROLOGY, 1995, 45 (08) :1488-1493
[6]   ETIOLOGY OF MOTOR OR SENSORY STROKE - A PROSPECTIVE-STUDY OF THE PREDICTIVE VALUE OF CLINICAL AND RADIOLOGICAL FEATURES [J].
CHIMOWITZ, MI ;
FURLAN, AJ ;
SILA, CA ;
PARANANDI, L ;
BECK, GJ .
ANNALS OF NEUROLOGY, 1991, 30 (04) :519-525
[7]   PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke [J].
del Zoppo, GJ ;
Higashida, RT ;
Furlan, AJ ;
Pessin, MS ;
Rowley, HA ;
Gent, M .
STROKE, 1998, 29 (01) :4-11
[8]   RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE [J].
DELZOPPO, GJ ;
POECK, K ;
PESSIN, MS ;
WOLPERT, SM ;
FURLAN, AJ ;
FERBERT, A ;
ALBERTS, MJ ;
ZIVIN, JA ;
WECHSLER, L ;
BUSSE, O ;
GREENLEE, R ;
BRASS, L ;
MOHR, JP ;
FELDMANN, E ;
HACKE, W ;
KASE, CS ;
BILLER, J ;
GRESS, D ;
OTIS, SM .
ANNALS OF NEUROLOGY, 1992, 32 (01) :78-86
[9]   Recommendations for standards regarding preclinical neuroprotective and restorative drug development [J].
Feinklestein, SP ;
Fisher, M ;
Furland, AJ ;
Goldstein, LB ;
Gorelick, PB ;
Kaste, M ;
Lees, KR ;
Traystman, RJ ;
Albers, GW ;
Anwer, UE ;
Ashwood, T ;
Barone, FC ;
Basta, SL ;
Bogousslavsky, J ;
Buchan, AM ;
Cady, WJ ;
Chan, PH ;
Clemens, JA ;
Cox, BF ;
Craddock, RE ;
Cramer, SC ;
del Zoppo, GJ ;
Dielrich, WD ;
Elliott, P ;
Faden, AI ;
Feuerstein, GZ ;
Ginsberg, MD ;
Gold, M ;
Greene, WL ;
Hall, ED ;
Hsu, CY ;
Hunter, AJ ;
Lai, M ;
Lesko, LM ;
Levy, DE ;
Li, FH ;
Locke, KW ;
Lodge, D ;
Lowe, D ;
Marcoux, FW ;
McCulloch, J ;
McDermott, J ;
Meibach, R ;
Messersmith, EK ;
Moseley, M ;
Moskowitz, MA ;
Mueller, AL ;
Munro, F ;
Nudo, RJ ;
Oeda, J .
STROKE, 1999, 30 (12) :2752-2758
[10]   CLINICAL-FEATURES OF PROVEN BASILAR ARTERY-OCCLUSION [J].
FERBERT, A ;
BRUCKMANN, H ;
DRUMMEN, R .
STROKE, 1990, 21 (08) :1135-1142